In Interventional cardiology (London, England)
Precision medicine has recently become widely advocated. It revolves around the individual patient, taking into account genetic, biomarker, phenotypic or psychosocial characteristics and uses biological, mechanical and/or personal variables to optimise individual therapy. In silico testing, such as the Virtual Physiological Human project, is being promoted to predict risk and to test treatments and medical devices. It combines artificial intelligence and computational modelling to select the best therapeutic option for the individual patient.
Hokken Thijmen W, Ribeiro Joana M, De Jaegere Peter P, Van Mieghem Nicolas M
Precision medicine, computational modelling, heart team